Certara (CERT) vs Phreesia (PHR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Certara (CERT) has outperformed Phreesia (PHR) over the past year, losing 30.7% versus a loss of 55.1%. Over five years, CERT leads with a -76.3% price change compared with -83.5% for PHR. Certara is the larger company by market cap ($1.37 billion vs $651.7 million), about 2.1 times the size.
On valuation, Phreesia trades at a lower forward P/E (6.6x vs 23.0x for Certara).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | PHR |
|---|---|---|
| Share price | $8.96 | $10.50 |
| Market cap | $1.37B | $651.74M |
| 1-day change | -3.34% | +2.44% |
| YTD return | +1.70% | -37.94% |
| 1-year return | -30.70% | -55.15% |
| 5-year return | -76.32% | -83.51% |
| P/E ratio (TTM) | — | 61.76 |
| Forward P/E | 23.04 | 6.64 |
| EPS (TTM) | $-0.14 | $0.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.30 | $24.25 |
| 52-week low | $4.45 | $7.77 |
| Distance from 52-week high | -32.63% | -56.69% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -3.79% | +34.00% |
| Average volume | 3.09M | 743.85K |
| Shares outstanding | 152.54M | 62.07M |
| Employees | 1,515 | 1,789 |
| Sector | Technology | Consumer Discretionary |
| Industry | Computer Software: Prepackaged Software | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Certara is about 2.1 times larger than Phreesia by market value ($1.37B vs $651.74M).
- CERT has outperformed PHR by 24.4 percentage points over the past year.
- The two companies sit in different sectors: Certara in Technology and Phreesia in Consumer Discretionary.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Technology · Computer Software: Prepackaged Software · 1,515 employees
About Phreesia
PHR stock →Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Consumer Discretionary · Business Services · 1,789 employees
CERT vs PHR FAQ
Which is bigger, Certara or Phreesia?
Certara (CERT) is larger, with a market capitalization of $1.37B compared with $651.74M for Phreesia (PHR).
Which stock has performed better over the past year, CERT or PHR?
CERT returned -30.70% over the past 12 months, compared with -55.15% for PHR (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Phreesia in the same industry?
No. Certara is in the Technology sector, while Phreesia is in Consumer Discretionary.